A relatively small trial of an inhaled protein treatment for COVID-19 from U.K. biotech company Synairgen has seen startling results, cutting odds of severe symptoms by almost 80 percent. Meanwhile, a gunman opened fire at the New Jersey home of a U.S. District Judge Sunday, killing her son. Click here to subscribe now to Flashback, OZY’s newest podcast: https://megaphone.link/HSW9425294283